Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Diabetes is a common cause of sight impairment and many patients experience significant functional and practical difficulties as a result of poor vision which can be treated using the diagnosis and treatment. Diabetic eye disease devices are medical devices used to treat and diagnose renal complications caused by diabetes. The common type of diabetic eye diseases include diabetic retinopathy, diabetic macular edema, cataract, and glaucoma. Moreover these disease cause damage that can lead to poor vision or even blindness. More recently non-biodegradable or biodegradable devices with various corticosteroids for intraocular use as well as intraocular injection are under clinical trial in the treatment of diffuse diabetic macular edema which is ultimately fueling the demand for diabetic eye disease devices market
The driving factor for the growth of diabetic eye disease devices market is increasing geriatric population from 65-74 age group suffering from diabetic eye diseases as this disease causes blindness as well as vision loss also eye floaters or transparent spots and dark strings float in the person’s field of vision creating problem therefore there is need for diabetic eye disease devices. Besides increasing demand for diabetic eye diseases devices had led the demand for advanced innovative device for the diagnosis and better treatment. Also growing prevalence of diabetic eye diseases and eye injury, hormone replacement therapy, hypertension and obesity is further propelling the demand for diabetic eye disease devices market
The exclusive COVID 19 impact analysis report by Axiom MRC provides a 3600 analysis of micro and macro-economic factors on the diabetic eye disease devices market. In addition, complete analysis of changes on the diabetic eye disease devices market expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on global economies, international trade, business investments, GDP and marketing strategies of key players present in the market. COVID-19 impact on the diabetic eye disease devices market was moderate as safety concern and many hospital had been shut down for few months which has ultimately hampered the growth of market
The diabetic eye disease devices market is segmented based on by device type, by disease, by end user and geography
The diabetic eye disease devices are available in different device types including surgery, ophthalmic diagnostic & monitoring equipment and vision care
Surgery is further bifurcated to cataract surgery devices, glaucoma surgery devices, refractive surgery devices, microkeratome, vitreo retinal surgery devices, and ophthalmic lasers. Cataract Surgery Devices is further sub segmented to intra ocular lens (iol) includes sub segment like monofocal, multifocal, toric, accomodating, ophthalmic viscoelastic devices (ovd) includes cohesive, dispersive, and phacoemulsification devices, Glaucoma surgery devices further includes glaucoma drainage devices, glaucoma lasers, stents and implants, systems, Ophthalmic lasers further includes excimer laser, femtosecond laser, yag laser, glaucoma lasers, photocoagulation lasers. Ophthalmic diagnostic & monitoring equipment is further bifurcated to optical coherence tomographers (oct scanners), fundus cameras, ophthalmoscopes, slit lamps, visual field analyzers/perimeters, wavefront aberrometers, ophthalmic ultrasound imaging systems, autorefractors/phoropters, tonometers, keratometers, corneal topographers, retinoscope, pachymeter, specular microscope, biometers, optotype projectors, dioptometers. Fundus Cameras is further sub segmented to non-mydriatic, mydriatic. Vision care further includes contact lens, spectacles. Ophthalmic diagnostic & monitoring equipment are widely used for the diagnosis disease related to the retina and cornea by measuring affix lenses and refractive errors. The ophthalmic diagnostic is used to perform diagnostic fluorescein angiography or angioscopy of the retina and iris vasculature.
The diabetic eye disease devices are accessible for different eye disease like diabetic retinopathy, diabetic macular edema (dme), cataract, glaucoma
Diabetic retinopathy is one of the leading causes of blindness in the population. The prevalence of diabetic retinopathy increases with duration of diabetes and nearly all patients with Type 1 and more than 60% with Type 2 diabetes develop some signs of retinopathy after 20 years duration. In addition adequate pre-surgery panretinal photocoagulation and metabolic control are useful in reducing intraoperative fibrin formation. Besides ophthalmoscopy, fundus photography, and fluorescein angiography are the standard tools to diagnose diabetic retinopathy
The diabetic eye disease devices has major end use in hospitals, ophthalmic clinics
Ophthalmic clinics majorly deals with the diagnosis, treatment and prevention of diseases of the eye and visual system. However diabetic eye disease devices has pivotal role for surgery in hospital providing advanced technique to diagnose the diabetic eye disease patient. Beside inflow of diabetic eye disease patient in hospital further fuel the demand for diabetic eye disease devices market
Geographically the global diabetic eye disease devices market is studied for the following region North America, Europe, Asia-Pacific and Rest of the world (RoW)
North America is anticipated to lead in the global diabetic eye disease devices market attributing to increasing adoption of advanced products and devices for diagnosis and treatment. Beside technology advancement for the product and growing cases of diabetic eye disease is further fueling the demand for diabetic eye disease devices market. On the other hand Asia Pacific is expected to witness significant growth during the forecast period.
The key players in diabetic eye disease devices market are Aaren Scientific Inc., Actavis plc, Alcon Inc., CooperVision AG, Essilor International S.A., Johnson & Johnson, Nidek Co., Ltd., Novartis AG, STAAR Surgical Company, Valeant Pharmaceuticals International, Inc., Lumenis, Abbott Medical Optics, Bausch & Lomb, Carl Zeiss Meditec, Ellex Medical Lasers Ltd., IRIDEX Corp., Meridian, Quantel, Rhein Medical, Synergetics USA Inc. and Topcon Corp. among others.
March 2019: Verily and Google have jointly developed a machine learning algorithm to power automated screening with the goal of detecting diabetic retinopathy (DR) and diabetic macular oedema (DME), two of the leading causes of preventable blindness in adults. Further machine learning algorithm could be helpful in many other areas of the world where there are not enough eye doctors to screen a growing population of people with diabetes.
April 2018: FDA had permitted marketing of artificial intelligence-based device to detect certain diabetes-related eye problems. The device, called IDx-DR, is a software program that uses an artificial intelligence algorithm to analyze images of the eye taken with a retinal camera called the Topcon NW400. In addition, FDA will continue to facilitate the availability of safe and effective digital health devices that may improve patient access to needed health care.
The report analyses the global diabetic eye disease devices market based on by device type, by disease, by end user and geography. The diabetic eye disease devices are available in different device types including surgery, ophthalmic diagnostic & monitoring equipment and vision care. The diabetic eye disease devices are accessible for different eye disease like diabetic retinopathy, diabetic macular edema (dme), cataract, glaucoma. The diabetic eye disease devices has major end use in hospitals, ophthalmic clinics. Geographically the global diabetic eye disease devices market is studied for the following region North America, Europe, Asia-Pacific and Rest of the world (RoW)
The key players in diabetic eye disease devices market are Aaren Scientific Inc., Actavis plc, Alcon Inc., CooperVision AG, Essilor International S.A., Johnson & Johnson, Nidek Co., Ltd., Novartis AG, STAAR Surgical Company, Valeant Pharmaceuticals International, Inc., Lumenis, Abbott Medical Optics, Bausch & Lomb, Carl Zeiss Meditec, Ellex Medical Lasers Ltd., IRIDEX Corp., Meridian, Quantel, Rhein Medical, Synergetics USA Inc. and Topcon Corp. among others.
Why to buy this report:
